πŸ‡ΊπŸ‡Έ FDA
Patent

US 10874709

Conjugate of salicylic acid and peptide

granted A61KA61K31/60A61K38/00

Quick answer

US patent 10874709 (Conjugate of salicylic acid and peptide) held by CAREGEN CO., LTD. expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/60, A61K38/00, A61K38/08, A61K38/10